Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Myriad Genetics (MYGN) Interest Coverage Ratio (2016 - 2025)

Myriad Genetics (MYGN) has disclosed Interest Coverage Ratio for 16 consecutive years, with 1.3 as the latest value for Q4 2025.

  • On a quarterly basis, Interest Coverage Ratio rose 97.67% to 1.3 in Q4 2025 year-over-year; TTM through Dec 2025 was 36.88, a 16.39% increase, with the full-year FY2025 number at 36.88, up 16.39% from a year prior.
  • Interest Coverage Ratio was 1.3 for Q4 2025 at Myriad Genetics, up from 6.13 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 1.3 in Q4 2025 to a low of 227.4 in Q2 2023.
  • A 5-year average of 61.47 and a median of 50.67 in 2024 define the central range for Interest Coverage Ratio.
  • Peak YoY movement for Interest Coverage Ratio: tumbled 666.52% in 2023, then soared 97.67% in 2025.
  • Myriad Genetics' Interest Coverage Ratio stood at 86.2 in 2021, then skyrocketed by 32.71% to 58.0 in 2022, then skyrocketed by 39.85% to 34.89 in 2023, then crashed by 59.69% to 55.71 in 2024, then skyrocketed by 97.67% to 1.3 in 2025.
  • Per Business Quant, the three most recent readings for MYGN's Interest Coverage Ratio are 1.3 (Q4 2025), 6.13 (Q3 2025), and 219.47 (Q2 2025).